Similar Items: The Economic Burden of Metabolic Dysfunction‐Associated Steatohepatitis (MASH) With Cirrhosis: A Systematic Review
- Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
- Molecular Quantification of Fibrogenesis and Macrophage Activation Associate With Clinical Worsening in Patients With Cirrhosis
- Glimpse into the role of Kupffer cells in a spheroid model of metabolic dysfunction-associated steatohepatitis (MASH)
- Noncoding RNA Transcripts Based Molecular Phenotyping of MASLD and MASH Patients
- From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies
- Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)